您的位置: 首页 > 农业专利 > 详情页

POLY-N-ACETYLGLUCOSAMINE (PNAG / DPNAG) BINDING PEPTIDES AND PROCEDURES FOR USING IT
专利权人:
BETH ISRAEL DEACONESS MEDICAL CENTER, INC.; INC.;THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;THE BRIGHAM AND WOMENS HOSPITAL
发明人:
PIER, GERALD, B.,CAVACINI, LISA,KELLY-QUINTOS, CASIE, ANNE,POSNER, MARSHALL, R.
申请号:
DK05770709
公开号:
DK1745075T3
申请日:
2005.04.21
申请国别(地区):
DK
年份:
2013
代理人:
摘要:
The present invention relates to peptides, particularly human monoclonal antibodies, that bind specifically to poly-N-acetyl glucosamine (PNAG), such as Staphylococcal PNAG, in acetylated, partially acetylated and/or fully deacetylated form. The invention further provides methods for using these peptides in the diagnosis, prophylaxis and therapy of infections by bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Some antibodies of the invention enhance opsonophagocytic killing and in vivo protection against bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Compositions of these peptides, including pharmaceutical compositions, are also provided, as are functionally equivalent variants of such peptides.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充